Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for ...
GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of Concept ...
Here are the new classifications and regions for winter sports for Auburn High, Opelika, Beauregard, Loachapoka and Lee-Scott Academy: ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果